EP2 antagonists (Pfizer)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameEP2 antagonists (Pfizer)
Drug Alias NamePF-04852946PF-00212062
ClassificationSmall molecules
Mechanisms of ActionProstaglandin E2 inhibitorsReproductive system modulatorsProstanoid EP2 receptor antagonists +[4] 
TargetsProstaglandin E2Prostanoid EP2 receptor
Therapy Area/IndicationsFractures, BonePainEndometriosis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsFractures, BonePainEndometriosis +[4] 

Other Information

ATC CodeN/A
Related LinksN/A